DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

van der Hiel B, Haanen JBAG, Stokkel MPM. et al.
Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: Response monitoring and resistance prediction with positron emission tomography and tumor characteristics (REPOSIT): Study protocol of a phase II, open-label, multicenter study.

BMC Cancer 2017;
17: 649

Download Bibliographical Data

Search in:
Access: